Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT05658354 Recruiting - Metabolic Syndrome Clinical Trials

Cognitive Rehabilitation in People With Metabolic Syndrome and Mild Cognitive Deficits

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months. Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.

NCT ID: NCT05653596 Recruiting - Breast Cancer Clinical Trials

VR-based Intervention for Cognitive Restoration

CHEERS
Start date: December 10, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to test the efficacy of a nature-based cognitive intervention to restore cognitive function among women treated for breast cancer.

NCT ID: NCT05653154 Recruiting - Clinical trials for Cognitive Impairment

Preoperative Survey

Start date: November 29, 2022
Phase:
Study type: Observational

This study will examine preoperative concerns in older adults through the use of a self-administered questionnaire. The development of this questionnaire will involve adapting survey questions from previously validated studies, creating new questions, and generating a comprehensive questionnaire.

NCT ID: NCT05649800 Recruiting - Stroke Clinical Trials

Vascular mEchanisms in, Stroke, dePression, dementiA, and deliRum: The VESPAR Project

VESPAR
Start date: March 17, 2023
Phase:
Study type: Observational

The goal of this observational study is to determine the feasibility of using integrated Transcranial Doppler Ultrasonography or Near Infrared Spectroscopy to detect changes in cerebral autoregulation and neurovascular coupling in healthy, stroke, dementia, depression and delirium populations. We also aim to: - Determine the optimal stimulus for neurovascular coupling - To derive sample size estimates for a future study - To develop a multilevel, multivariate model that can be applied to future datasets

NCT ID: NCT05641480 Recruiting - Alzheimer Disease Clinical Trials

Technical R&D and Demonstration of Intelligent Medical Care in Alzheimer's Disease's Management

Start date: June 3, 2022
Phase: N/A
Study type: Interventional

This is a study on patient registry, and the sample size of this clinicaltrial is designed in group sequential design. According to the diagnostic criteria, the subjects are divided into SCD group, MCI group and mild dementia group. At the early stage of treatment, the investigators give participants transcutaneous electrical acupoint stimulation and music therapy according to the guidance of TCM syndrome differentiation. Participants can treat themselves at home after the investigators give them intelligent device and music,and according to the TCM syndrome score, neuropsychological scale, curative effect evaluation of daily life ability scale, determining the optimal comprehensive treatment plan,and phase in the treatment of participants with food, clothing, shelter, line, and life aspects of health education and guidance, a total of 24 weeks of treatment.

NCT ID: NCT05641090 Recruiting - Clinical trials for Elderly With Type 2 Diabetes

Effects of Nordic Walking in Water on Cerebrovascular Function and Cognitive Impairment in Elderly With Type 2 Diabetes

Start date: December 16, 2021
Phase: N/A
Study type: Interventional

Nordic walking in water would more advantage than normal daily life in cerebrovascular function and cognitive function in elderly with type 2 diabetes.

NCT ID: NCT05640141 Recruiting - Alzheimer Disease Clinical Trials

Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

PRESAGE
Start date: January 26, 2022
Phase:
Study type: Observational

The main aim of the study is to characterize and understand the pathological mechanisms underlying the motoric cognitive risk syndrome, which is a predictor of Alzheimer disease.

NCT ID: NCT05637801 Recruiting - Alzheimer Disease Clinical Trials

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

Hope
Start date: December 13, 2022
Phase: N/A
Study type: Interventional

This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's disease. Approximately 530 subjects will be randomized to 12 months of daily treatment with either Active or Sham Sensory Stimulation Systems. Efficacy will be measured using the Alzheimer's Disease Cooperative Study- Activities of Daily Living (ADCS-ADL) assessment and a combined statistical test (CST) of the ADCS-ADL and the Mini-Mental State Exam (MMSE).

NCT ID: NCT05629871 Recruiting - Neuropathology Clinical Trials

Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?

ALZ-OREX
Start date: April 17, 2023
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) is characterised by a progressive loss of memory and cognitive function. In the early stages of AD, there is a progressive accumulation of molecules: β-amyloid peptides (Aβ) in the brain. There is a link between the accumulation of Aβ peptides and the deterioration of sleep, but current knowledge does not confirmed this link. The objective of this study is to define whether there is a link between cognitive decline and sleep disorders. If a correlation is found, this could allow earlier treatment of sleep disorders in the longer term in order to slow the development of AD.

NCT ID: NCT05625828 Recruiting - Aging Clinical Trials

Evaluation of the Effects of a Cognitive-Motor Fall Prevention Program on Fall Risk Factors

13EVAL
Start date: September 13, 2022
Phase: N/A
Study type: Interventional

The goal of this interventional study is to compare in community dwelling elderly people the effects of two physical activity programs to prevent accident falls : "SILVER XIII EQUILIBRE" program and "VIVIFRAIL" program, on several risks factors such as executive functions and functional capacities. Participants will perform a 1 hour physical activity session during 10 weeks and effects will be measured using a multidimensional test battery. "SILVER XIII EQUILIBRE" program contains cognitive-motor exercises where participants have to perform two tasks simultaneously such as answering math questions while walking whereas "VIVIFRAIL" program contains multifactorial exercises such as walking, balance training and resistance training in single-task condition. The main question it aims to answer is : • Does physical activity enriched with simultaneous cognitive exercises enhances the effects ?